Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity | NEJM
Special Article from The New England Journal of Medicine — Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity
Related Articles
DPP-1 Inhibitor Brensocatib in Bronchiectasis | NEJM
Quick Take Video Summary from The New England Journal of Medicine — DPP-1 Inhibitor Brensocatib in Bronchiectasis
Interview with Lauren Jatt on the efficacy of twice-yearly lenacapavir for preexposure prophylaxis and its implications for the development of an HIV vaccine. | NEJM
Audio Interview from the New England Journal of Medicine — Interview with Lauren Jatt on the efficacy of twice-yearly lenacapavir for preexposure prophylaxis and its…
Cholelithiasis, Cholecystitis, and Choledocholithiasis | NEJM
An 80-year-old woman presented with a 3-day history of abdominal pain. Imaging revealed numerous small gallstones in the gallbladder and cystic duct, consistent with cholecystitis.
Cutaneous Leishmaniasis | NEJM
A 3-year-old boy presented with a 6-week history of ulcerated plaques with rolled borders and satellite papules on his left lower leg. He had recently…
Southern Tick-Associated Rash Illness | NEJM
A 65-year-old man presented with 1-day history of a rash with a bull’s-eye appearance on his left hip. One week earlier, he had removed a…
Climate Change and Human Health — A Research Agenda for Action | NEJM
A new report from the National Academy of Medicine proposes a research agenda to address climate-related health risks and data gaps, emphasizing equity, innovation, and…
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy | NEJM
Metachromatic leukodystrophy (MLD) is an ultrarare, severe lysosomal storage disorder caused by a deficiency of arylsulfatase A (ARSA). We treated patients who had MLD with…
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis | NEJM
In bronchiectasis, neutrophilic inflammation is associated with an increased risk of exacerbations and disease progression. Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP…
Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study | NEJM
Treatment with fidanacogene elaparvovec, a recombinant adeno-associated virus (AAV) vector developed for the treatment of hemophilia B, led to sustained expression of the high-activity factor…
Enteral Nutrition in Hospitalized Adults | NEJM
This review considers enteral nutrition in the context of disease-related malnutrition, provides evidence for the use of enteral nutrition in hospitalized patients, and discusses practice…